Showing results (31-40 of 161) with videos related to
Sort By:
Pageof 17
Annals of Internal Medicine|October 18, 2000
Long-term outcomes of scleroderma renal crisisV D Steen, T A MedsgerArthritis and Rheumatism|February 14, 2012
Patterns and predictors of change in outcome measures in clinical trials in scleroderma: an individual patient meta-analysis of 629 subjects with diffuse cutaneous systemic sclerosisP A Merkel, N P Silliman, P J Clements, et al.Journal of General Internal Medicine|December 1, 1994
Evaluation of a simple office-based strategy for increasing influenza vaccine administration and the effect of differing reimbursement plans on the patient acceptance rateP A Merkel, G C CaputoThe Journal of Rheumatology|November 11, 1999
Endothelial and adrenergic dysfunction in Raynaud's phenomenon and sclerodermaR R Freedman, R Girgis, M D MayesAnnals of Internal Medicine|November 15, 1993
Autoantibody reactive with RNA polymerase III in systemic sclerosisY Okano, V D Steen, T A MedsgerAnnals of Internal Medicine|May 1, 1986
The toxicity of D-penicillamine in systemic sclerosisV D Steen, S Blair, T A MedsgerArthritis and Rheumatism|January 11, 1992
Autoantibody to U3 nucleolar ribonucleoprotein (fibrillarin) in patients with systemic sclerosisY Okano, V D Steen, T A MedsgerLancet (London, England)|September 4, 1999
Acute effect of nitric oxide on Raynaud's phenomenon in sclerodermaR R Freedman, R Girgis, M D MayesThe Journal of Rheumatology|February 24, 2001
Abnormal responses to endothelial agonists in Raynaud's phenomenon and sclerodermaR R Freedman, R Girgis, M D MayesClinical and Experimental Rheumatology|July 25, 2006
Epidemiology of Wegener's granulomatosis: Lessons from descriptive studies and analyses of genetic and environmental risk determinantsA D Mahr, T Neogi, P A MerkelPageof 17